Japan Hemostats Market Size To Reach $292.6 Million By 2030

Japan Hemostats Market Growth & Trends

The Japan hemostats market size is anticipated to reach USD 292.6 million by 2030 and is anticipated to expand at a CAGR of 6.40% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing geriatric population and the rising competition among key industry participants are the major factors contributing to the market growth. The companies operating in the industry such as Johnson & Johnson Services, Inc. and Baxter are developing novel hemostatic agents.

The geriatric population in Japan is increasing and is at a high risk of developing various diseases, including cancer, cardiovascular diseases, neurological disorders, obesity, and diabetes. According to the article published by the World Economic Forum in September 2023, over 10% of the population, or 1 in 10 individuals in Japan, are aged 80 or older. Elderly patients often need specialized care and are susceptible to injuries & slow-healing wounds. As the population leans toward a more active lifestyle, there has been a rise in the number of everyday injuries and wounds among this demographic. Chronic illnesses commonly lead to the need for surgical procedures in older patients, which further drives the Japan hemostats market expansion.

Furthermore, the rising incidences of cancer across Japan are expected to propel the market growth. According to the statistics published by the International Agency for Research On Cancer (IARC) for 2022, around 1,005,157 new cancer cases were reported in Japan in 2022. Furthermore, hemostats are widely used in cancer surgeries to control bleeding. Thus, the rising prevalence of cancer in Japan is anticipated to boost market growth.

 Request a free sample copy or view report summary: Japan Hemostats Market Report

Japan Hemostats Market Report Highlights

• Oxidized regenerated cellulose-based hemostats segment dominated the product segment with more than 46.46% share in 2023 owing to the proven efficacy and widespread adoption of these hemostats

• The combination hemostats segment is expected to grow at the fastest CAGR over the forecast period

• Matrix and gel hemostats segment dominated the formulation segment. However, the sponge hemostats segment is anticipated to witness the fastest growth in the coming years

• Based on the application, the orthopedic surgery segment held the largest market share owing to the large number of orthopedic procedures being conducted in Japan. On the other hand, cardiovascular surgery segment is anticipated to grow fastest over the forecast period

• On the basis of end-use, the hospitals & clinics dominated the market with a revenue share of 63.37% in 2023. However, the ambulatory surgical centers are expected to register the fastest CAGR over the forecast period

Japan Hemostats Market Segmentation

Grand View Research has segmented the Japan hemostats market based on end-use, product, application, and formulation:

Japan Hemostats Product Outlook (Revenue, USD Million, 2018 - 2030)

• Thrombin-based Hemostats

• Oxidized Regenerated Cellulose-based Hemostats

• Combination Hemostats

• Others

Japan Hemostats Formulation Outlook (Revenue, USD Million, 2018 - 2030)

• Matrix & Gel Hemostats

• Sponge Hemostats

• Powder Hemostats

• Others

Japan Hemostats End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals & Clinics

• Ambulatory Surgical Centers

• Casualty Care Centers

• Others

Japan Hemostats Application Outlook (Revenue, USD Million, 2018 - 2030)

• Orthopedic Surgery

• General Surgery

• Neurological Surgery

• Cardiovascular Surgery

• Others

List of key players in the Japan Hemostats Market

• Johnson & Johnson Services, Inc.

• CryoLife, Inc

• Integra LifeSciences Corporation

• Cohera Medical, Inc.

• Pfizer

• Cohesion Technologies

• B. Braun Melsungen AG

• Baxter

• Medtronic

• BD